Progenity: Sean Lavin

Progenity announced that Sean Lavin has been appointed as VP of business development, strategy, and investor relations. He will work with the company's senior management on strategy, business development, investor outreach, and shareholder value creation. He runs his own firm, Alpha Lavin Advisors, that focuses on value creation in the medical device and diagnostic sectors. Lavin previously served as a managing director in equity research at BTIG and Lazard Capital Markets covering these sectors. He joined Lazard in 2008 as the senior medical technology and diagnostic analyst and moved to BTIG as a senior healthcare analyst in 2013.